For dermatologist Brooke Jackson, MD, a love of learning and science began at an early age. Her father, Marvin Jackson, MD, was the chair of the pathology department at Howard University, and her mother was a public school teacher in Washington, DC. “I grew up in the halls of Howard University Medical School and fondly remember looking at preserved human body parts in the cases that lined the walls of...
For dermatologist Brooke Jackson, MD, a love of learning and science began at an early...
In business lexicon, internal marketing is the promotion of an organization’s...
Whether you are addressing acne and pigmentation concerns or simply seeking to...
Nutritional counseling can help support positive outcomes for aesthetic patients,...
Silagen Topical Recovery Gel from NewMedical Technology helps reduce...
The InMode AccuTite radiofrequency-assisted lipolysis (RFAL) device features...
Resurface Glycolic Renewal Serum from Neostrata features a 12 percent...
Cynosure TempSure Surgical radiofrequency (RF) technology—a new addition to...
 The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released the results of its 2019 annual member survey on aesthetic procedures. Overall, facial plastic surgery procedures increased 6 percent last year compared to 2018, and demand for nonsurgical aesthetic...
|
Soliton, a medical device company using a Rapid Acoustic Pulse (RAP) platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, has filed for Special 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) for its Generation II...
|
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released the results of its 2019 annual member survey on aesthetic procedures. Overall, facial plastic surgery procedures increased 6 percent last year compared to 2018, and demand for nonsurgical aesthetic procedures is up 13 percent compared to 2018. And the patients seeking these procedures are younger than in years past. Seventy-four percent of respondents reported an increase in minimally invasive procedures (neurotoxins, fillers, skin treatments) in patients under age 30, and 73 percent of AAFPRS members believe there will be a greater emphasis on earlier maintenance for patients starting in their 20s and 30s, to forestall bigger procedures and surgery for longer.
The most common surgical procedures performed by AAFPRS members in 2019 were rhinoplasty, facelift (including partial facelifts) and blepharoplasty. The number of facelifts performed in 2019 increased by 3 percent, while forehead lifts increased 6 percent since 2018.
Despite the growth in surgical procedures, noninvasive and minimally invasive cosmetic procedures accounted for 85 percent of the total number of procedures performed by AAFPRS members. The top treatments...
Soliton, a medical device company using a Rapid Acoustic Pulse (RAP) platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, has filed for Special 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) for its Generation II RAP device.
The Generation II RAP device is indicated for the same tattoo-removal therapy as the Generation I device, but is slightly modified for improved ease of use in the physician's office. Although, similar technology was utilized in the company’s pivotal cellulite and proof of concept keloid scar trials, only the tattoo-removal indication will be reviewed by the FDA in this submission.
The Special 510(k) filing states the device is indicated as an accessory to the 1,064 nm Q-switched laser for tattoo removal on the arms, legs and torso in Fitzpatrick Skin Type I-III individuals. Clinical trials have demonstrated that using the company’s RAP device in conjunction with a Q-switched laser allows for multiple passes of laser treatment in a single treatment session, resulting in accelerated fading in comparison to stand-alone laser treatment.
For more information www.soliton.com...
Two phase 3 studies of Foamix Pharmaceuticals’ FMX103 (minocycline, 1.5% foam) were published in the Journal of the American Academy of Dermatology (online January 26). Foamix conducted FX2016-11 and FX2016-12 (Studies 11 & 12) to support the New Drug Application (NDA) submission of FMX103, which is currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe papulopustular rosacea in adults.
Both studies demonstrated high statistically significant superiority of FMX103 compared with vehicle in both primary endpoints of absolute inflammatory lesion reduction and Investigator's Global Assessment (IGA) treatment success at Week 12 where approximately half of subjects achieved treatment success as defined by the latter endpoint. There was a statistically significant reduction in inflammatory lesions versus vehicle as early as Week 4 of treatment, and all subsequently assessed time points throughout the entire treatment course of the study.
The majority of treatment-emergent adverse events (TEAEs) were mild to moderate, and subjects were no more likely to experience TEAEs from FMX103 than from vehicle treatment. More than 95 percent of subjects using...
Think of your most valuable employees—the ones who know the ins and outs of your practice, keep your office running smoothly, and are respected and liked by patients and staff. Now suppose those star staffers suddenly quit. How would that affect your day-to-day practice and profits?
Owners of thriving aesthetic practices know that knowledgeable, motivated, long-term employees are key to their success. And it’s not just high turnover rates that can damage a practice. Unhappy, dissatisfied team members can also wreak havoc on your bottom line. “If staff members are not happy, it can... more »
Patients who suffer from rosacea may exhibit any number of uncomfortable symptoms, from flushing and dilated capillaries to papules, pustules and ocular irritation. Treatment options similarly vary, as do theories as to what the underlying causes of rosacea may be. While recent research highlights cardiovascular links and explores the potential role of facial microorganisms, experts agree that the best treatments for rosacea target the chronic inflammation of the skin and body, and require a holistic approach to patient care. Patients most commonly present with erythematotelangiectatic... more »
At age six, Julius Few, MD, already knew exactly what he wanted to be when he grew up: a doctor—specifically, a surgeon. His inspiration: Dr. Quincy, a forensic pathologist played by actor Jack Klugman in the 1970s television series Quincy M.E. Of course, Dr. Quincy’s fictitious patients were dead, but that fact escaped the young Julius Few.
“Quincy was a sleuth,” says Dr. Few. “When I saw him operating on people, I thought that was the coolest thing and I knew that was what I wanted to do.”
Today, Dr. Few is the director and founder of The Few Institute for... more »
